At a glance
ClinicalIndex Comparison RecordN/ACompleted· 314 enrolled
Drug / intervention
Right heart catheterization (RHC)procedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection (PHINDER)
In Brief
An observational study evaluating Right heart catheterization (RHC) for Interstitial Lung Disease and Pulmonary Hypertension. Completed, enrolled 314 participants across 42 sites.
Detailed Summary
Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInterstitial Lung Disease, Pulmonary Hypertension
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedMar 2023
Enrollment StartAug 2023
Primary CompletionMar 2026
Study CompletionApr 2026
TodayJul 2026
First PostedMar 20, 2023
Enrollment StartAug 11, 2023
Primary CompletionMar 13, 2026
Study CompletionApr 29, 2026
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 3.3 years ago
Interventions
Right heart catheterization (RHC)procedure
RHC to evaluate pulmonary hemodynamics